Reneo Pharmaceuticals, Inc.

RPHM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$110,761$27,632$19,927$124,660
Short-Term Investments$0$75,331$81,246$23,010
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,242$3,659$5,180$6,064
Total Curr. Assets$113,003$106,622$106,353$153,734
Property Plant & Equip (Net)$1,795$733$1,745$212
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$109$81$84$78
Total NC Assets$1,904$814$1,829$290
Other Assets$0$0$0$0
Total Assets$114,907$107,436$108,182$154,024
Liabilities
Payables$2,968$8,717$1,893$2,022
Short-Term Debt$536$331$404$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,026$8,798$4,827$4,180
Total Curr. Liab.$10,530$18,177$7,124$6,202
LT Debt$549$642$1,059$0
Deferred Rev, NC$0$0$0$167
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$7$29$611
Total NC Liab.$549$649$1,088$611
Other Liabilities$0$0$0$0
Cap. Leases$0$973$1,463$0
Total Liabilities$11,079$18,826$8,212$6,813
Equity
Pref Stock$114,907$0$0$0
Common Stock$1$3$3$3
Retained Earnings-$154,724-$218,474-$136,683-$84,728
AOCI$0$8-$43$34
Other Equity$258,551$307,073$236,693$231,902
Total Equity$103,828$88,610$99,970$147,211
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$114,907$107,436$108,182$154,024
Net Debt-$109,676-$26,659-$18,464-$124,660